• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medexus Pharmaceuticals Inc (OP:MEDXF)

3.480 +0.030 (+0.87%)
Delayed Quote Updated: 11:23 AM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,250
Open 3.450
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 3.450
Today's Range 3.474 - 3.480
52wk Range 1.800 - 3.960
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
April 11, 2023
Annual revenue expected to exceed US$107 million for fiscal year ended March 31, 2023, an all-time record, including fiscal Q4 2023 revenue of at least US$28 million 
From Medexus Pharmaceuticals Inc
Via GlobeNewswire

Performance

52-Week Range 12.1% below 52-week high
3.480
1.8052W Low 3.9652W High
1 Week 0.8% below 1-week high
3.261W Low 3.511W High

Medexus Pharmaceuticals Inc (MEDXF) traded between $1.80 and $3.96 over the past 52 weeks and last traded at $3.48, 12.1% below its 52-week high. Over the past week it ranged between $3.26 and $3.51.

Past 12 Months
+3.0%
-4.7%
-3.3%
+20.3%
+55.4%
+71.4%
1W +$0.10
1M -$0.17
3M -$0.12
6M +$0.59
YTD +$1.24
1Y +$1.45

MEDXF was +71.4% over the past year, +20.3% over six months, +55.4% year to date, +3.0% in the last week.

12 Months vs Market
MEDXF
+71.4%
DIA
+12.2%
SPY
+14.5%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months MEDXF returned +71.4% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.5%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.09× 3-mo avg
Today 1,250 3-mo avg 13.4K
1W
11.6K
1M
11.9K
3M
13.4K
6M
13.6K
YTD
13.1K
1Y
13.5K

MEDXF most recently traded 1,250 shares against a 3-month average daily volume of 13.4K.

More News

Read More
News headline image
Medexus Announces New License Deal for Topical Terbinafine
March 22, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces US$58.5 million in New Credit Facilities
March 08, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Featured in Coverage of the 35th Annual Roth Conference
March 06, 2023
Via Investor Brand Network
News headline image
Medexus to Participate in 35th Annual Roth Conference
March 06, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
February 08, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Welcomes Two New Board Members
February 06, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
February 01, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
January 31, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
January 12, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
November 08, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Schedules Second Quarter 2023 Conference Call
November 02, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
October 06, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
September 29, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
January 28, 2022
From MicroCap Rodeo
Via AccessWire
News headline image
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
From Stock News Now
Via AccessWire
News headline image
Making a Difference When You Invest? Medexus Says It Improves Lives ↗
November 10, 2021
Via Benzinga
News headline image
Sidoti Microcap Virtual Conference
November 05, 2021
From Sidoti & Company, LLC
Via AccessWire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021 ↗
August 18, 2021
Via Benzinga
News headline image
Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021
August 10, 2021
From Medexus Pharmaceuticals Inc.
Via AccessWire
News headline image
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
From Stock News Now
Via AccessWire
Topics Cannabis
News headline image
Sidoti Microcap Virtual Conference
May 18, 2021
From Sidoti & Company, LLC
Via AccessWire

Frequently Asked Questions

Is Medexus Pharmaceuticals Inc publicly traded?
Yes, Medexus Pharmaceuticals Inc is publicly traded.
What exchange does Medexus Pharmaceuticals Inc trade on?
Medexus Pharmaceuticals Inc trades on the OTC Traded
What is the ticker symbol for Medexus Pharmaceuticals Inc?
The ticker symbol for Medexus Pharmaceuticals Inc is MEDXF on the OTC Traded
What is the current price of Medexus Pharmaceuticals Inc?
The current price of Medexus Pharmaceuticals Inc is 3.480
When was Medexus Pharmaceuticals Inc last traded?
The last trade of Medexus Pharmaceuticals Inc was at 10/20/26 11:23 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap